Peldesine

小分子

佩尔德西内

7B646RJ70F | BCX-34 | UNII-7B646RJ70F | BC3 | DTXSID10158107 | 9-(3-Pyridylmethyl)-7H-9-deazaguanine | PELDESINE [MART.] | Peldesine [USAN] | PELDESINE | peldesine,BCX-34 | 2-Amino-3,5-dihydro-7-(3-pyridylmethyl)-4H-pyrrolo[3,2-d]pyrimidin-4-one | AKOS040

Peldesine

P647043-5mg

5mg

-20°C储存

超低温冰袋运输

Peldesine (BCX 34) is a potent, competitive, reversible and orally active purine nucleoside phosphorylase (PNP) inhibitor with IC 50 s of 36 nM, 5 nM, and 32 nM for human, rat, and mouse red blood cell (RBC) PNP , respectively. Peldesine is also a T-cell proliferation inhibitor with an IC 50 of 800 nM. Peldesine has the potential for cutaneous T-cell lymphoma, psoriasis and HIV infection research In Vitro Peldesine (BCX 34; 0-50 µM; 72 hours; Jurkat cells) could inhibit the T-cell proliferation completely at a concentration of less than 10 μM, in the presence of dGuo (10 μM). In contrast, the B-cell proliferation is not affected by Peldesine. Peldesine (BCX 34) suppresses T-cell immune reaction in an IL-2-independent manner, and this means that Peldesine might affect a late phase rather than an early stage in T-cell activation. Peldesine also, in the presence but not in the absence of deoxyguanosine, inhibits human leukemia CCRF-CEM T-cell proliferation with an IC 50 of 0.57 μM but not rat or mouse T-cell proliferation up to 30 μM. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Proliferation AssayCell Line: Jurkat cells Concentration: 0 µM, 10 µM, 20 µM, 30 µM, 40 µM, 50 µM Incubation Time: 72 hours Result: In the presence of 10 µM dCuo, had a complete inhibitory effect for T-cell lines. In Vivo Oral bioavailability of Peldesine in rats is 76%. Peldesine is orally active in elevating plasma inosine in rats (2-fold at 30 mg/kg), in suppressing ex vivo RBC PNP activity in rats (98% at 3 h. 100 mg/kg), and in suppressing ex vivo skin PNP in mice (39% at 3 h, 100 mg/kg). MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:IC50: 36 nM (Human RBC PNP), 5 nM (Rat RBC PNP), 32 nM (Mouse RBC PNP), and 800 nM (Human T-cell proliferation), Ki: 23 nM (Human RBC PNP),HIV

Peldesine（BCX 34）是一种强效、竞争性、可逆和口服活性嘌呤核苷磷酸化酶（PNP）抑制剂，对人、大鼠和小鼠红细胞（RBC）PNP的 IC 50 s 分别为 36 nM、5 nM 和 32 nM。Peldesine 还是一种 T 细胞

133432-71-0

C12H11N5O

241.25 g/mol

135413525

C1=CC(=CN=C1)CC2=CNC3=C2N=C(NC3=O)N

2-amino-7-(pyridin-3-ylmethyl)-3,5-dihydropyrrolo[3,2-d]pyrimidin-4-one

1S/C12H11N5O/c13-12-16-9-8(4-7-2-1-3-14-5-7)6-15-10(9)11(18)17-12/h1-3,5-6,15H,4H2,(H3,13,16,17,18)

DOHVAKFYAHLCJP-UHFFFAOYSA-N

C1=CC(=CN=C1)CC2=CNC3=C2N=C(NC3=O)N

135413525

133432-71-0

9-(3-pyridylmethyl)-7H-9-deazaguanine;BCX 34;BCX-34;peldesine

DMSO : 200 mg/mL (829.02 mM; Need ultrasonic)

3

3

2

241.096 Da

241.096 Da

96.200 Ų

18

0

369.000

0

1

0.100